Interleukin-1, inflammasomes, autoinflammation and the skin
- PMID:22653747
- DOI: 10.4414/smw.2012.13590
Interleukin-1, inflammasomes, autoinflammation and the skin
Abstract
Interleukin 1, one of the first cytokines discovered in the 1980s, and a potent mediator of fever, pain and inflammation, is at present experiencing a revival in biology and medicine. Whereas the mechanism of activation and secretion of interleukin 1β, which critically regulates the function of this molecule, has remained mysterious for some 30 years following its discovery, the identification of a new cytoplasmic complex of proteins regulating IL-1β activation and secretion has carried our understanding of the role of IL1 in biology and disease one big step further. The inflammasomes, recently identified innate immune complexes that sense intracellular danger- (e.g. uric acid, ATP, cytoplasmic DNA) or pathogen-associated molecular patterns (e.g. muramyl dipeptide, flagellin, anthrax lethal toxin), are now known to be responsible for triggering inflammation in response to several molecular patterns, including, for example, uric acid, a danger-associated molecular pattern and trigger of gout. Dysregulation of inflammasome function is however also the cause of a family of genetic autoinflammatory diseases known as cryopyrin-associated periodic syndromes (CAPS) characterised by recurrent episodes of fever, urticarial-like skin lesions, systemic inflammation and arthritis. In mouse models recapitulating mutations observed in CAPS, neutrophilic inflammation of the skin is a cardinal feature, in a manner similar to several autoinflammatory diseases with skin involvement such as PAPA (pyoderma gangrenosum, acne and pyogenic arthritis) and Schnitzler's syndrome, in which IL-1β very probably plays a pathogenic role. In this article the role of the inflammasome in IL-1 biology, autoinflammation and disease is reviewed, together with new avenues for the therapy of these diseases.
Similar articles
- A dermatologic perspective on autoinflammatory diseases.Marzano AV, Damiani G, Genovese G, Gattorno M.Marzano AV, et al.Clin Exp Rheumatol. 2018 Jan-Feb;36 Suppl 110(1):32-38. Epub 2018 May 3.Clin Exp Rheumatol. 2018.PMID:29742056Review.
- Contribution of the inflammasomes to autoinflammatory diseases and recent mouse models as research tools.Heymann MC, Rösen-Wolff A.Heymann MC, et al.Clin Immunol. 2013 Jun;147(3):175-84. doi: 10.1016/j.clim.2013.01.006. Epub 2013 Feb 4.Clin Immunol. 2013.PMID:23411032Review.
- Gain of function mutation and inflammasome driven diseases in human and mouse models.Cordero MD, Alcocer-Gómez E, Ryffel B.Cordero MD, et al.J Autoimmun. 2018 Jul;91:13-22. doi: 10.1016/j.jaut.2018.03.002. Epub 2018 Mar 30.J Autoimmun. 2018.PMID:29610014Review.
- [Inflammasome and interleukin 1].Jéru I, Amselem S.Jéru I, et al.Rev Med Interne. 2011 Apr;32(4):218-24. doi: 10.1016/j.revmed.2010.02.013. Epub 2010 Jun 11.Rev Med Interne. 2011.PMID:20541850French.
- Autoinflammatory syndromes.Galeazzi M, Gasbarrini G, Ghirardello A, Grandemange S, Hoffman HM, Manna R, Podswiadek M, Punzi L, Sebastiani GD, Touitou I, Doria A.Galeazzi M, et al.Clin Exp Rheumatol. 2006 Jan-Feb;24(1 Suppl 40):S79-85.Clin Exp Rheumatol. 2006.PMID:16466630Review.
Cited by
- The Inhibition of Inflammasome by Brazilian Propolis (EPP-AF).Hori JI, Zamboni DS, Carrão DB, Goldman GH, Berretta AA.Hori JI, et al.Evid Based Complement Alternat Med. 2013;2013:418508. doi: 10.1155/2013/418508. Epub 2013 Apr 16.Evid Based Complement Alternat Med. 2013.PMID:23690844Free PMC article.
- The Pathogenetic Effect of Natural and Bacterial Toxins on Atopic Dermatitis.Park KD, Pak SC, Park KK.Park KD, et al.Toxins (Basel). 2016 Dec 23;9(1):3. doi: 10.3390/toxins9010003.Toxins (Basel). 2016.PMID:28025545Free PMC article.Review.
- Is acute myeloid leukemia a liquid tumor?Ohanian M, Faderl S, Ravandi F, Pemmaraju N, Garcia-Manero G, Cortes J, Estrov Z.Ohanian M, et al.Int J Cancer. 2013 Aug 1;133(3):534-43. doi: 10.1002/ijc.28012. Epub 2013 Feb 4.Int J Cancer. 2013.PMID:23280377Free PMC article.Review.
- Epidural Fever: Hiding in the Shadows.Khanna P, Jain S, Thariani K, Sharma S, Singh AK.Khanna P, et al.Turk J Anaesthesiol Reanim. 2020 Oct;48(5):350-355. doi: 10.5152/TJAR.2020.50. Epub 2020 Apr 27.Turk J Anaesthesiol Reanim. 2020.PMID:33103138Free PMC article.Review.
- Development, standardization and testing of a bacterial wound infection model based on ex vivo human skin.Schaudinn C, Dittmann C, Jurisch J, Laue M, Günday-Türeli N, Blume-Peytavi U, Vogt A, Rancan F.Schaudinn C, et al.PLoS One. 2017 Nov 15;12(11):e0186946. doi: 10.1371/journal.pone.0186946. eCollection 2017.PLoS One. 2017.PMID:29140982Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous